Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects

Area of Science:

• Genetics
• Internal Medicine
• Biochemistry

Background:

• Hereditary hemochromatosis is an autosomal recessive disorder linked to the HFE gene, prevalent in European descent populations.
• Approximately 10% of individuals of European descent carry the HFE gene, with 3-5 per 1,000 being homozygotes at risk of severe iron overload.

Purpose of the Study:

• To highlight the importance of early diagnosis and screening for hereditary hemochromatosis.
• To discuss the role of HFE gene mutations in iron overload disorders.
• To explore the potential of genetic testing for identifying at-risk individuals.

Main Methods:

• Review of clinical manifestations and diagnostic approaches for hereditary hemochromatosis.
• Discussion of HFE gene structure and its association with iron metabolism.
• Emphasis on screening tests like transferrin saturation and serum ferritin concentration.
• Introduction of polymerase chain reaction (PCR)-based genetic testing for HFE mutations.

Main Results:

• HFE gene mutations are a primary cause of hereditary hemochromatosis, leading to potentially lethal iron overload.
• Early detection through screening tests and genetic analysis allows for timely intervention.
• Venesection therapy is effective in managing excess iron but cannot reverse existing organ damage.

Conclusions:

• Physicians should maintain a high index of suspicion for hereditary hemochromatosis due to nonspecific symptoms.
• Widespread screening, including genetic testing for the HFE gene, is cost-effective for early detection.
• Future research should focus on non-HFE genetic or environmental factors contributing to iron overload.